The raised guidance and strong adjusted EBITDA margin expansion signal improving operational leverage, but the GAAP net loss widened significantly due to litigation settlements and acquisition costs. The VitalConnect acquisition adds a new revenue stream but also integration risk. Monitor the Q4 2026 earnings for the first full quarter of VitalConnect contribution and progress on margin targets.
Price Chart
Executive Summary
iRhythm reported Q3 2026 revenue of $221.6M (+14.9% YoY), slightly below the $222.2M consensus, and GAAP net loss per share of -$0.90, well below the Street consensus of $0.02. Adjusted net income per diluted share was $0.82, reflecting strong operational leverage. The company raised FY 2026 revenue guidance to $890M-$895M and adjusted EBITDA margin guidance to 15.5%-16.0%, including the VitalConnect acquisition closed on October 5, 2026, and closed a new $300M revolving credit facility on November 3, 2026.
Key Financial Metrics
Key Facts
- Q3 2026 revenue $221.6M, +14.9% YoY vs $192.9M, slightly below $222.2M consensus
- GAAP net loss $29.9M ($0.90 per share) vs GAAP net loss $5.2M ($0.16) in Q3 2025
- Adjusted net income $27.8M ($0.82 per diluted share) vs adjusted net loss $2.0M ($0.06) in Q3 2025
- Gross margin 74.2%, up 310 bps YoY, including a $3.1M one-time tariff refund benefit
- Adjusted EBITDA $51.2M (23.1% margin), up from $21.6M (11.2% margin) in Q3 2025
- FY 2026 revenue guidance raised to $890M-$895M (from $875M-$885M), including ~$16M from VitalConnect
- FY 2026 adjusted EBITDA margin guidance raised to 15.5%-16.0% (from 12.0%-13.0%)
- Completed VitalConnect acquisition on October 5, 2026
- Closed $300M senior secured revolving credit facility on November 3, 2026
- GAAP operating expenses $197.0M included $49.8M in litigation settlements and $6.6M in business transformation costs
- Free cash flow was negative $11.5M in Q3 2026 vs positive $20.1M in Q3 2025, partly due to $50.0M in Baxter patent litigation settlement payments
Financial Impact
Revenue $221.6M (+14.9% YoY), GAAP net loss $29.9M, adjusted net income $27.8M, guidance raised to $890M-$895M revenue and 15.5%-16.0% adjusted EBITDA margin
Risk Factors
- GAAP net loss widened to $29.9M from $5.2M in Q3 2025, driven by $49.8M in litigation settlements
- Free cash flow turned negative $11.5M vs positive $20.1M a year ago, partly due to litigation payments
- Revenue slightly missed consensus of $222.2M, though guidance was raised
- Integration risk from the VitalConnect acquisition and associated business transformation costs
- One-time tariff refund of $3.1M boosted gross margin; sustainability of margin expansion without such benefits is uncertain
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001388658-26-000093 |
| Document: irtc-20261105.htm | 0001388658-26-000093 |
| Document: 0001388658-26-000093-index-headers.html | 0001388658-26-000093 |
| Document: 0001388658-26-000093-index.html | 0001388658-26-000093 |
| Document: 0001388658-26-000093.txt | 0001388658-26-000093 |
| 8-K Data (Synthetic) | 0001388658-26-000093 |
Track record
31 reports on IRTC
8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
- Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 11, 20265d ago Press Release Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 5, 202611d ago 8-K Mixed 6/10 Viewing No price data
- Nov 5, 202611d ago Press Release Bullish 6/10 Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
- Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers